Acepodia logo

Acepodia

POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER

49 employees · est. 2016 · Alameda, United States

VS
XNK Therapeutics logo

XNK Therapeutics

INDIVIDUALIZED NK CELL THERAPIES

9 employees · est. 2012 · Sweden

XNK Therapeutics is the older company (2016 vs 2012); Acepodia is the larger of the two.

Side-by-Side Comparison

Acepodia XNK Therapeutics
Founded
2016 2012 older
Headquarters
Alameda, United States Sweden
Employees
49 larger 9
Industry
Biotechnology, Health Care, Health and Wellness Health and Wellness, Pharmaceutical
Funding Stage
Series D Grant
Total Funding
$256.00M $197.70M
Funding Rounds
3 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Acepodia, Clinical-stage, Cancer Cell Immunotherapy, Off-the-shelf, NK Cells, Antibody-cell Conjugation, Cell Therapy, Oncology, Immune Effector Cells, Solid Tumors, Hematologic Cancers, Immunotherapeutic Strategies, Interdisciplinary Technology NK Cell Therapy, Cancer Treatment, Clinical-stage, Hematological Malignancies, Solid Tumors, Evencaleucel, Isatuximab, Stem Cell Transplantation, Multiple Myeloma, Proprietary Technology Platform, GMP Facility, Karolinska Institute, Autologous Therapy, Clinical Study
Website
acepodia.com xnktherapeutics.com
Acepodia logo

About Acepodia

Acepodia is a clinical-stage biotechnology company founded in 2016, with a focus on developing innovative and highly effective cell therapies for cancer patients. The company's slogan, "POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER," encapsulates its mission. Acepodia leverages its An...

XNK Therapeutics logo

About XNK Therapeutics

XNK Therapeutics is a clinical-stage biotechnology company with a mission to develop individualized and unique natural killer (NK) cell-based cancer therapies. Their R&D pipeline focuses on addressing unmet medical needs in hematological malignancies and solid tumors. Their most advanced product can...

We will tell you when either one moves

BounceWatch watches Acepodia and XNK Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Acepodia and XNK Therapeutics — by email.

Frequently Asked Questions

Acepodia — POWERFUL, ACCESSIBLE CELL THERAPIES FOR PATIENTS WITH CANCER. XNK Therapeutics — INDIVIDUALIZED NK CELL THERAPIES. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Acepodia has raised $256.00M while XNK Therapeutics has raised $197.70M.
Acepodia and XNK Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Acepodia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Acepodia on 11 Sep 2024, and XNK Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy